Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Acutaas Chemicals

Market Cap: ₹96.5b

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ARS Pharmaceuticals

Market Cap: US$1.4b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Avantor

Market Cap: US$9.1b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Financière de Tubize

Market Cap: €5.6b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

SCHOTT Pharma KGaA

Market Cap: €4.5b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Madrigal Pharmaceuticals

Market Cap: US$6.5b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Stevanato Group

Market Cap: US$6.8b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Adaptive Biotechnologies

Market Cap: US$1.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Axsome Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Centessa Pharmaceuticals

Market Cap: US$1.6b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.

Pharma Mar

Market Cap: €1.5b

A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Travere Therapeutics

Market Cap: US$1.5b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Sandoz Group

Market Cap: CHF 17.2b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

BioNTech

Market Cap: US$23.5b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

SKAN Group

Market Cap: CHF 1.6b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Ascendis Pharma

Market Cap: US$9.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$38.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Revolution Medicines

Market Cap: US$7.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Soleno Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Sarepta Therapeutics

Market Cap: US$3.7b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

SK bioscienceLtd

Market Cap: ₩3.2t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

TG Therapeutics

Market Cap: US$5.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Tempus AI

Market Cap: US$11.0b

Operates as a healthcare technology company.

Biogen

Market Cap: US$19.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Medpace Holdings

Market Cap: US$8.8b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Halozyme Therapeutics

Market Cap: US$6.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Exelixis

Market Cap: US$12.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Corcept Therapeutics

Market Cap: US$7.9b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

ADMA Biologics

Market Cap: US$4.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Daan Gene

Market Cap: CN¥8.6b

Researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China.